Characteristics of the study group (62 patients)
Parameter/category . | No. (%) . |
|---|---|
| Age, 60 y or older | 23 (37) |
| Diagnosis | |
| AML | 31 (50) |
| Salvage 1 | |
| CRD1 less than 12 mo | 11 (18) |
| CRD1 12 mo or longer | 8 (13) |
| Second or subsequent salvage | 12 (19) |
| MDS | 8 (13) |
| Salvage 1, CRD1 less than 12 mo | 6 (10) |
| Second or subsequent salvage | 2 (3) |
| CML, blastic phase | 11 (18) |
| Salvage 1 | 7 (11) |
| Second or subsequent salvage | 4 (6) |
| ALL | 12 (19) |
| Salvage 1 | 4 (6) |
| Second or subsequent salvage | 8 (13) |
| Karyotype | |
| AML-MDS | |
| Favorable | 1 (2) |
| Diploid | 20 (32) |
| Unfavorable | 18 (29) |
| CML | |
| −Ph only | 4 (6) |
| Ph + other | 7 (11) |
| ALL | |
| Ph ± other | 2 (3) |
| Diploid | 1 (2) |
| Other | 9 (15) |
Parameter/category . | No. (%) . |
|---|---|
| Age, 60 y or older | 23 (37) |
| Diagnosis | |
| AML | 31 (50) |
| Salvage 1 | |
| CRD1 less than 12 mo | 11 (18) |
| CRD1 12 mo or longer | 8 (13) |
| Second or subsequent salvage | 12 (19) |
| MDS | 8 (13) |
| Salvage 1, CRD1 less than 12 mo | 6 (10) |
| Second or subsequent salvage | 2 (3) |
| CML, blastic phase | 11 (18) |
| Salvage 1 | 7 (11) |
| Second or subsequent salvage | 4 (6) |
| ALL | 12 (19) |
| Salvage 1 | 4 (6) |
| Second or subsequent salvage | 8 (13) |
| Karyotype | |
| AML-MDS | |
| Favorable | 1 (2) |
| Diploid | 20 (32) |
| Unfavorable | 18 (29) |
| CML | |
| −Ph only | 4 (6) |
| Ph + other | 7 (11) |
| ALL | |
| Ph ± other | 2 (3) |
| Diploid | 1 (2) |
| Other | 9 (15) |
AML indicates acute myeloid leukemia; CRD1, duration of first complete response; MDS, myelodysplastic syndrome; CML, chronic myeloid leukemia; and ALL, acute lymphoid leukemia.